Skip to content
10-Q

Quarterly Report

Protagonist Therapeutics, Inc PTGX

0001558370-25-010534

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 62.21M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.24M sh
Shares Diluted Q2 2025 · Jun 30, 2024 61.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 63.91M sh
Capex Q2 2025 · Jun 30, 2025 $1.36M
Capex Q2 2025 · Jun 30, 2024 $270K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $96.58M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $241.19M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $168.54M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $97.25M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $355.64M
Stockholders Equity Q2 2025 · Jun 30, 2025 $668.02M
Stockholders Equity Q2 2025 · Mar 31, 2025 $689.05M
Stockholders Equity Q2 2025 · Dec 31, 2024 $675.3M
Stockholders Equity Q2 2025 · Jun 30, 2024 $541.32M
Stockholders Equity Q2 2025 · Mar 31, 2024 $560.44M
Stockholders Equity Q2 2025 · Dec 31, 2023 $336.68M
Current Liabilities Q2 2025 · Jun 30, 2025 $35.51M
Current Liabilities Q2 2025 · Dec 31, 2024 $47.4M
Total Liabilities Q2 2025 · Jun 30, 2025 $49.99M
Total Liabilities Q2 2025 · Dec 31, 2024 $69.43M
Current Assets Q2 2025 · Jun 30, 2025 $602.53M
Current Assets Q2 2025 · Dec 31, 2024 $591.64M
Total Assets Q2 2025 · Jun 30, 2025 $718.01M
Total Assets Q2 2025 · Dec 31, 2024 $744.73M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.55
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.73
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.50
Eps Diluted Q2 2025 · Jun 30, 2024 $2.77
Eps Basic Q2 2025 · Jun 30, 2025 −$0.55
Eps Basic Q2 2025 · Jun 30, 2025 −$0.73
Eps Basic Q2 2025 · Jun 30, 2024 −$0.50
Eps Basic Q2 2025 · Jun 30, 2024 $2.89
Sga Expense Q2 2025 · Jun 30, 2025 $10.55M
Sga Expense Q2 2025 · Jun 30, 2025 $22.29M
Sga Expense Q2 2025 · Jun 30, 2024 $9.44M
Sga Expense Q2 2025 · Jun 30, 2024 $24.35M
Rd Expense Q2 2025 · Jun 30, 2025 $37.04M
Rd Expense Q2 2025 · Jun 30, 2025 $72.93M
Rd Expense Q2 2025 · Jun 30, 2024 $33.52M
Rd Expense Q2 2025 · Jun 30, 2024 $67.25M
Net Income Q2 2025 · Jun 30, 2025 −$34.77M
Net Income Q2 2025 · Jun 30, 2025 −$46.43M
Net Income Q2 2025 · Jun 30, 2024 −$30.62M
Net Income Q2 2025 · Jun 30, 2024 $176.72M
Operating Income Q2 2025 · Jun 30, 2025 −$42.04M
Operating Income Q2 2025 · Jun 30, 2025 −$61.35M
Operating Income Q2 2025 · Jun 30, 2024 −$38.79M
Operating Income Q2 2025 · Jun 30, 2024 $167.52M